Page last updated: 2024-12-05

phytane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Phytane is a branched alkane with the molecular formula C20H42. It is a biomarker for the presence of ancient photosynthetic organisms, particularly green algae. Phytane is produced through the degradation of chlorophyll, specifically the phytol side chain. Its presence in sedimentary rocks and crude oil indicates the presence of ancient life forms and can be used to study paleoclimates and environmental changes. Phytane is also a potential source of biofuels, due to its abundance in certain oil deposits. Research on phytane focuses on understanding its origins, distribution, and potential applications. It is particularly relevant to studies in geochemistry, paleontology, and bioenergy.'

Cross-References

ID SourceID
PubMed CID12523
CHEBI ID48937
MeSH IDM0053165

Synonyms (23)

Synonym
einecs 211-332-2
unii-27uzx1q8tr
27uzx1q8tr ,
hsdb 8346
phytan
hexadecane, 2,6,10,14-tetramethyl-
phytane
2,6,10,14-tetramethylhexadecane
CHEBI:48937
638-36-8
LMPR0104010019
2,6,10,14-tetramethyl-hexadecane
2,6,10,14-tetramethylhexdecane
hexadecane,2,6,10,14-tetramethyl-
GGYKPYDKXLHNTI-UHFFFAOYSA-N
phytane, analytical standard
DTXSID70862339
phytane 10 microg/ml in isooctane
hexadecane, 2,6,10,14-tetramethyl-; phytane (6ci); 2,6,10,14-tetramethylhexadecane; phytan; tetrahydroneophytadiene
FT-0739716
tetrahydroneophytadiene
Q171701
mfcd00060946
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diterpeneA C20 terpene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (7.69)18.7374
1990's3 (11.54)18.2507
2000's13 (50.00)29.6817
2010's6 (23.08)24.3611
2020's2 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.33 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index52.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]